Staff Reports
China has formally nominated Dr. Song Li to be the next director-general of the World Health Organization. The move is the news — not a distant policy debate. That nomination sets up a real contest over who will steer global health policy at a time when the W.H.O. is under heavy scrutiny and U.S. involvement has been uneven. Americans should be paying attention.
China’s nomination of Song Li: what actually happened
Beijing announced Dr. Song Li as its official candidate to succeed the current W.H.O. director-general. Song is a seasoned Chinese health official with experience in maternal and newborn care and a short stint as a visiting scholar abroad. On paper, she is qualified. In practice, her candidacy is being presented by China as part of a push to gain more influence in multilateral organizations — and that is the real story here.
Why this matters to American interests and global health
The World Health Organization sets rules and priorities for pandemics, vaccines, and health aid worldwide. If the W.H.O. director-general is someone closely tied to a government that pushes a particular agenda, the agency’s decisions will tilt that way. That’s not theory; it’s the concern critics raised when the U.S. first withdrew support years ago and again when the U.S. later changed course. With the U.S. now sending mixed signals about funding and membership, any seat China wins at the top of the W.H.O. gives Beijing louder sway over global health policy.
Song’s credentials and the political reality
Song Li brings relevant health experience. She worked on China’s pandemic-era maternity protocols and led a women-and-children health department. But she also sits on organs tied to the Chinese Communist Party. Call it what it is: a candidate who blends public-health experience with clear political ties. Other countries have put forward candidates too — from Europe, the Middle East, Africa, and Asia — so this will be a competitive election. Still, China’s pitch is plainly strategic: to place a trusted ally inside the W.H.O. leadership ranks.
A clear choice or a power play? The stakes and the finish
Ask yourself what you want from the next W.H.O. director-general. Do you want a transparent leader who defends open science and resists political interference? Or do you accept a director whose nomination can be read as a diplomatic win for an authoritarian state seeking global leverage? This nomination is a wake-up call. The U.S. — and its allies — should stop treating W.H.O. governance as a bureaucratic sidebar. They must push for accountability, clear rules about conflicts of interest, and a truly global balance of power in health governance. Otherwise, the agency that coordinates pandemic responses may end up answering first to geostrategic calculations — and that is a risk no country should accept quietly.
